Patents by Inventor Suzanne Gordon

Suzanne Gordon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150110898
    Abstract: The present invention generally relates to methods and compositions for treating pathogenic vaginal biofilms. More specifically, the invention relates to pharmaceutical compositions comprising a combination of boric acid and diethylaminetetracetic acid (EDTA) and to methods of using such compositions to treat or prevent biofilm formation associated with vaginal infections, such as bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), trichomoniasis or mixed infections.
    Type: Application
    Filed: December 23, 2014
    Publication date: April 23, 2015
    Inventors: Suzanne Gordon, Dawn Flynn
  • Patent number: 8956663
    Abstract: The present invention generally relates to methods and compositions for treating pathogenic vaginal biofilms. More specifically, the invention relates to pharmaceutical compositions comprising a combination of boric acid and diethylaminetetracetic acid (EDTA) and to methods of using such compositions to treat or prevent biofilm formation associated with vaginal infections, such as bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), trichomoniasis or mixed infections.
    Type: Grant
    Filed: December 10, 2012
    Date of Patent: February 17, 2015
    Assignee: Toltec Pharmaceuticals, LLC
    Inventors: Suzanne Gordon, Dawn Flynn
  • Patent number: 8349368
    Abstract: The present invention generally relates to methods and compositions for treating pathogenic vaginal biofilms. More specifically, the invention relates to pharmaceutical compositions comprising a combination of boric acid and diethylaminetetracetic acid (EDTA) and to methods of using such compositions to treat or prevent biofilm formation associated with vaginal infections, such as bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), trichomoniasis or mixed infections.
    Type: Grant
    Filed: November 26, 2008
    Date of Patent: January 8, 2013
    Assignee: Toltec Pharmaceuticals, LLC
    Inventors: Suzanne Gordon, Dawn Flynn
  • Publication number: 20090181106
    Abstract: The present invention generally relates to methods and compositions for treating pathogenic vaginal biofilms. More specifically, the invention relates to pharmaceutical compositions comprising a combination of boric acid and diethylaminetetracetic acid (EDTA) and to methods of using such compositions to treat or prevent biofilm formation associated with vaginal infections, such as bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), trichomoniasis or mixed infections.
    Type: Application
    Filed: November 26, 2008
    Publication date: July 16, 2009
    Inventors: Suzanne Gordon, Dawn Flynn